Cookies help us improve your ABPI online experience. If you accept their use, continue using our site. or, find out more about cookies.
International Policy Manager (Trade)
We are seeking an exceptional person to lead in the development and implementation of the ABPI’s trade policy agenda.
Apply now. Closing date 17 December 2021.
Invest and innovate to keep UK life sciences globally competitive
Richard Torbett outlines the case for investing in our sector ahead of the autumn's Comprehensive Spending Review.
ABPI publishes third annual report on UK clinical research
The ABPI's report calls for lessons from COVID-19 to be used to revitalise the post-pandemic clinical research environment.
ABPI 2021 Code of Practice
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
ABPI & AAC ATMP Roadmap launch webinar | 9 Dec 2021
We are delighted to invite you to the launch of the brand new Accelerated Access Collaborative/ABPI Advanced Therapeutic Medicinal Products (ATMP) Roadmap.
Online Workshop on SMC: How to prepare and submit to SMC | 13-14 Dec 2021
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
We represent our members, using their insight and experience to tell the story of how they change the lives of millions of people every day.
30 Jun 2020
Publication ref: REP-0056-0616
Publication size: 0.27 MB
Technical statement and Q&A on the temporary change to 2019 disclosure data as a result of the COVID-19 pandemic.